High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Chipotle Mexican Grill (NYSE:CMG) rose around 3. 5% in pre-market trading on Wednesday after Minnesota health officials said they have no ongoing concerns about the company following a recent salmonella outbreak investigation.
AstraZeneca (NASDAQ:AZN) shares climbed around 6% on Wednesday after Reuters reported that there are “no discussions” between the company and Bristol Myers Squibb (NYSE:BMY) regarding a potential merger, contradicting recent speculation that had unsettled investors. The report eased concerns surrounding a deal that, if completed, would have created a pharmaceutical group valued at close to $400 billion.
Revenue rose 92% and beat estimates in the first report as a public company
Chipotle Mexican Grill’s stock is taking a hit after the chain pulled ingredients tied to a Salmonella outbreak.
Yahoo Finance Senior Reporter Brooke DiPalma and Market Domination host Josh Lipton take a closer look at one of Tuesday's trending stories: Chipotle (CMG) pulling its jalapeños due to salmonella concerns. Watch the video above to learn more. Yahoo Finance's AlphaSpace is a premium investment platform that combines data, charting, news, analysis, and more to help retail investors understand markets.
Chipotle Mexican Grill has pulled jalapeños from several Minnesota restaurants following a state Salmonella outbreak that has infected more than 100 people.
The pharma giant now expects adjusted earnings of $2.66 to $2.76 per share, down from a prior range of $5.04 to $5.16
Merck slashed its profit outlook for the year due to charges tied to its acquisition of cancer biotech company Terns Pharmaceuticals.
Investors questioned whether combining AstraZeneca with Bristol Myers would strengthen growth enough to justify the financial and regulatory risks.
The Bithumb crypto exchange is preparing for a 2028 initial public offering (IPO) after reorganizing its business and setting out a two-year program to strengthen accounting, compliance and risk controls. South Korea’s largest cryptocurrency exchange said it expects to complete internal-control ...
Apple's Latest Acquisition Signals a Bigger Push Into AI and Advanced Chips
One of the largest global pharma companies would be created if a deal were to materialise.
The merger would be one of the biggest pharma deals ever. AstraZeneca’s market capitalization stood at $264 billion as of Friday’s close, while Bristol Myers Squibb had a total valuation of $133 billion.
If maintained until close, the decline would be the stock’s biggest one-day percentage fall since the day of the 2024 U.S. presidential election.
Tesla Inc. CEO Elon Musk has dismissed reports of the EV giant mulling the sale of its Chinese arm that could have reportedly paved the way for a potential merger with Space Exploration Technologies Corp.. Elon Musk Says Sale Has...
Elon Musk's net worth has fallen below where it stood before SpaceX's initial public offering priced
Tesla had already reportedly prepped for the idea in the event that Beijing invades Taiwan.
Jersey Mike's sandwich chain made it from the Jersey Shore to the financial capital of the world.
China's CXMT just pulled off one of the most explosive stock market debuts in history, and memory giants with triple-digit gains on the books are now facing a sector-wide reckoning that could upend the entire bull case for DRAM and NAND.
Investing.com -- Seaport Research Partners downgraded Warner Bros Discovery to Neutral from Buy, arguing that a prolonged delay to its proposed acquisition by Paramount Skydance reduces the attractiveness of the stock despite potential upside if the transaction is ultimately completed. The downgrade follows Paramount Skydance's decision to put the acquisition on hold until as late as June 1, 2027, as it seeks to address legal challenges from the Writers Guild and several U.S. state attorneys gen
Steer clear of the entertainment company’s shares for now—there’s just not enough regulatory clarity for investors.
The entertainment giant reported a notable insider sale amid legal challenges to its merger with Paramount Skydance.
According to a court filing from Friday, the companies have agreed to pause the transaction until five days after the court issues a final decision on the merger, or until June 1, 2027.
According to TheFly, HSBC analysts initiated their coverage of SpaceX with a ‘Hold’ rating and a price target of $115.
SpaceX (NASDAQ:SPCX) short sellers have amassed an estimated $15. 5 billion in unrealized gains as the aerospace company’s shares continue to retreat from the highs reached shortly after its public market debut, according to data from Ortex Technologies cited by Reuters.
Investing.com - Short sellers targeting SpaceX (NASDAQ:SPCX) had accumulated an estimated $15.5 billion in paper profit through Tuesday, July 22, according to Ortex Technologies data cited by Reuters, as the stock continued to unwind its spectacular post-IPO surge.
Investing.com -- Apple’s trade secret lawsuit named OpenAI and io Products directly as defendants, alongside two former Apple employees, but the litigation is unlikely to derail OpenAI’s IPO plans, according to Ross Carmel, a partner and IPO expert at Sichenzia Ross Ference Carmel LLP.
Editor’s Note: This story has been updated to include a response from an Intel spokesperson. SK hynix Inc (NASDAQ:SKHY) said Tuesday it has neither pursued nor decided to acquire Intel Corp‘s (NASDAQ:INTC) Ohio semiconductor campus, denying a media report that claimed the South Korean memory chipmaker was in talks to buy the site. SK hynix Responds to Korea JoongAng Daily Report SK hynix issued the clarification in a Korea Exchange filing after Korea JoongAng Daily reported that the company was
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
